Diseases, Conditions, Syndromes

The pandemic has reached a plateau, but for how long?

The U.S. appears to have reached a plateau with the omicron subvariant that's surged this spring, but it's too early to know if positive trends will stick, according to Tom Inglesby, who recently returned to his role directing ...

Medications

Nasal antiviral blocks SARS-CoV-2 infection in mice

SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed ...

Diseases, Conditions, Syndromes

Omicron lasts three days less than Delta for boosted: study

People who are vaccinated and have had a booster shot against COVID-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

Vaccination

German panel recommends booster for recipients of 4 vaccines

Germany's independent vaccination advisory panel is recommending a booster shot with a messenger RNA vaccine for people who have had a full course of four Chinese, Indian and Russian COVID-19 vaccines that aren't currently ...

page 3 from 8